CME Group Inc. (CME) is Savant Capital LLC’s 8th Largest Position
Savant Capital LLC reduced its position in shares of CME Group Inc. (NASDAQ:CME) by 11.8% during the second quarter, Holdings Channel reports. The institutional investor owned 90,060 shares of the company’s stock after selling 12,020 shares during the period. CME Group comprises approximately 2.5% of Savant Capital LLC’s investment portfolio, making the stock its 8th largest position. Savant Capital LLC’s holdings in CME Group were worth $8,772,000 at the end of the most recent reporting period.
Several other large investors have also recently made changes to their positions in the stock. Glenmede Trust Co. NA raised its stake in shares of CME Group by 2.2% in the first quarter. Glenmede Trust Co. NA now owns 32,517 shares of the company’s stock worth $3,122,000 after buying an additional 710 shares in the last quarter. Virginia Retirement System purchased a new stake in shares of CME Group during the first quarter worth about $500,000. CIBC World Markets Inc. bought a new position in CME Group during the first quarter worth approximately $860,000. Ngam Advisors L.P. boosted its position in CME Group by 8.9% in the first quarter. Ngam Advisors L.P. now owns 37,903 shares of the company’s stock worth $3,641,000 after buying an additional 3,094 shares during the last quarter. Finally, TIAA CREF Investment Management LLC boosted its position in CME Group by 21.8% in the first quarter. TIAA CREF Investment Management LLC now owns 989,117 shares of the company’s stock worth $95,005,000 after buying an additional 176,790 shares during the last quarter. 80.29% of the stock is owned by hedge funds and other institutional investors.
Shares of CME Group Inc. (NASDAQ:CME) traded down 0.13% during trading on Tuesday, reaching $103.93. 1,422,096 shares of the company’s stock traded hands. The stock has a market capitalization of $35.22 billion, a PE ratio of 26.24 and a beta of 0.83. The company has a 50 day moving average price of $106.84 and a 200 day moving average price of $99.23. CME Group Inc. has a 1-year low of $81.87 and a 1-year high of $110.35.
CME Group (NASDAQ:CME) last posted its quarterly earnings results on Thursday, July 28th. The company reported $1.14 EPS for the quarter, beating the consensus estimate of $1.11 by $0.03. The company earned $906 million during the quarter, compared to analysts’ expectations of $897.84 million. CME Group had a return on equity of 6.83% and a net margin of 38.22%. The firm’s revenue was up 10.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.95 EPS. On average, equities analysts forecast that CME Group Inc. will post $4.44 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Monday, September 26th. Shareholders of record on Friday, September 9th were issued a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 2.31%. The ex-dividend date of this dividend was Wednesday, September 7th. CME Group’s dividend payout ratio (DPR) is 60.61%.
A number of research analysts have commented on the stock. Deutsche Bank AG upped their target price on shares of CME Group from $110.00 to $111.00 and gave the company a “buy” rating in a research report on Friday, July 29th. JPMorgan Chase & Co. upped their target price on shares of CME Group from $99.00 to $106.00 and gave the company an “overweight” rating in a research report on Friday, July 29th. Barclays PLC decreased their target price on shares of CME Group from $100.00 to $99.00 and set an “equal weight” rating on the stock in a research report on Friday, July 29th. Zacks Investment Research raised shares of CME Group from a “sell” rating to a “hold” rating in a research report on Thursday, June 30th. Finally, Keefe, Bruyette & Woods upped their target price on shares of CME Group from $99.00 to $103.00 and gave the company a “market perform” rating in a research report on Friday, July 29th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $102.89.
In other news, Director Ronald A. Pankau sold 400 shares of CME Group stock in a transaction dated Thursday, August 11th. The stock was sold at an average price of $103.32, for a total value of $41,328.00. Following the transaction, the director now directly owns 4,382 shares of the company’s stock, valued at approximately $452,748.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director James E. Oliff sold 1,000 shares of CME Group stock in a transaction dated Friday, July 15th. The shares were sold at an average price of $102.30, for a total value of $102,300.00. The disclosure for this sale can be found here. 0.61% of the stock is owned by company insiders.
About CME Group
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.